European Society of Gene and Cell Therapy 2024 x Kactus

By Mallory Griffin

July 22, 2024

Join KACTUS at the European Society of Gene and Cell Therapy 2024 in Rome

We are excited to announce our participation in the European Society of Gene and Cell Therapy- ESGCT 2024- conference in Rome, Italy, from October 22nd to 25th. For the past 30 years, ESGCT has been instrumental in supporting scientists and clinicians in gene and cell therapy research, promoting knowledge exchange and collaboration between academia and industry. If you're interested in attending, there's still time to register for ESGCT 2024.

What is ESGCT?

The European Society of Gene and Cell Therapy (ESGCT) meeting brings together scientists, clinicians, and industry professionals from around the world to exchange knowledge, collaborate on challenges in the gene and cell therapy space, and help create connections through various presentations, workshops, and networking opportunities.

Event Overview

Venue: La Nuvola, Viale Asia 25, 00144 Roma (Car parking entry from Viale Europa 259)

For more information on how to get there, you can head to the ESGCT 2024 “How to Get There Page”.

Dates: October 22nd to 25th, 2024

Conference Day 1: Tuesday 22 October, 2024 9:00am - 8:30pm
Conference Day 2: Wednesday 23 October, 2024 8:30am- 7:30pm
Conference Day 3: Thursday 24 October, 2024 8:30am - 8:00pm
Conference Day 4: Friday 25 October, 2024 9:00am - 5:30pm

KACTUS Booth: #D40

Hotels and Accommodations

Attending the ESGCT 2024 Congress in Rome? Secure your stay with a range of accommodation options tailored for meeting attendees. The official booking portal offers a selection of hotels near the event venue, ensuring convenience and comfort. Benefit from special rates and easy booking through the dedicated ESGCT platform. For the best deals and to reserve your spot, visit the ESGCT 2024 accommodation page. We recommend booking as early as possible as Rome is a popular destination spot!

Event Schedule

The European Society of Gene and Cell Therapy (ESGCT) meeting will span four days, and will feature a variety of sessions aimed at collaboration and knowledge sharing. For a detailed overview of the daily schedule, including specific times and further information on each talk, please refer to the ESGCT full agenda. You can also look at the program at a glance for more of a general overview. Please note that the Exhibit Hall will be open everyday for as long as the space is open for the meeting.

ESGCT Day 1 Tuesday 22 October, 2024

9:00am - 1:00pm - Education Sessions
10:00am- 1:00pm - Clinical Trials and Communications Workshop
12:00pm - 2:00pm - Registration Opens
2:00pm - 4:00pm - Session 1
4:00pm - 4:30pm - Coffee Break 1
4:30pm - 7:00pm - Sessions 2
7:00pm - 8:30pm - Welcome Reception and Poster Session I (Odd numbers 1, 3, 5 …)

ESGCT Day 2 Wednesday 23 October, 2024

8:00am - 8:30am - Registration Opens
8:30am - 10:30am - Session 3
10:30am - 11:00am - Coffee Break
11:00am - 1:00pm - Session 4
1:00pm - 2:00pm - Lunch Break
2:00pm - 3:00pm - Poster Sessions II (Odd numbers 1, 3, 5 ...)
3:00pm - 5:00pm - Session 5
5:00pm - 5:30pm - Coffee Break
5:30pm - 7:30pm - Session 6

ESGCT Day 3 Thursday 24 October, 2024

8:00am - 8:30am - Registration Opens
8:30am - 10:30am - Session 7
10:30am - 11:00am - Coffee Break
11:00am - 1:00pm - Session 8
1:00pm - 1:30pm - ESGCT AGM
1:00pm - 2:00pm - Lunch Break
2:00pm - 3:00pm - Poster Sessions III (Even numbers 2, 4, 6 ...)
3:00pm - 5:30pm - Session 9
5:00pm - 5:30pm - Coffee Break
5:30pm - 7:00pm- Poster Sessions IV (Even numbers 2,4,6 ...)
5:30pm - 7:30pm - Session 10
8:00pm - Molecular Mingle

ESGCT Day 4 Friday 25 October, 2024

8:30am - 9:00am - Registration Opens
9:00am - 10:30am - Session 11
10:30am - 11:00am - Coffee Break
11:00am - 1:00pm Session 12
1:00pm - 2:30pm - Lunch Break
2:30pm - 4:45pm- Session 13
4:45pm - 5:30pm - Farewell Drinks

About KACTUS

KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 2500 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.